Success Metrics

Clinical Success Rate
80.0%

Based on 12 completed trials

Completion Rate
80%(12/15)
Active Trials
4(16%)
Results Posted
67%(8 trials)
Terminated
3(12%)

Phase Distribution

Ph early_phase_1
1
4%
Ph not_applicable
3
12%
Ph phase_1
1
4%
Ph phase_4
15
60%
Ph phase_3
5
20%

Phase Distribution

2

Early Stage

0

Mid Stage

20

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
1(4.0%)
Phase 1Safety & dosage
1(4.0%)
Phase 3Large-scale testing
5(20.0%)
Phase 4Post-market surveillance
15(60.0%)
N/ANon-phased studies
3(12.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.6%

12 of 17 finished

Non-Completion Rate

29.4%

5 ended early

Currently Active

4

trials recruiting

Total Trials

25

all time

Status Distribution
Active(5)
Completed(12)
Terminated(5)
Other(3)

Detailed Status

Completed12
Recruiting4
unknown3
Terminated3
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
4
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.0%)
Phase 11 (4.0%)
Phase 35 (20.0%)
Phase 415 (60.0%)
N/A3 (12.0%)

Trials by Status

unknown312%
not_yet_recruiting14%
completed1248%
terminated312%
withdrawn28%
recruiting416%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT06332781Phase 4

Intravesical Gentamicin to Prevent Recurrent UTI

Completed
NCT05138822Phase 1

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Completed
NCT05274672Phase 4

Role of Prophylactic Postoperative Antibiotics in HoLEP

Withdrawn
NCT07202832Not Applicable

Urine Alkalinization for UTI in Women: RCT

Not Yet Recruiting
NCT07186465Phase 4

Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis

Recruiting
NCT04959331Phase 4

Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.

Completed
NCT04502095Phase 4

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Completed
NCT05630833Phase 3

A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Completed
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting
NCT05652374Phase 4

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study

Recruiting
NCT05519072Phase 4

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA

Recruiting
NCT02021006Phase 3

Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract

Unknown
NCT04187144Phase 3

Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)

Completed
NCT04020341Phase 3

A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)

Completed
NCT05600023Phase 4

The Effectiveness of Single Antibiotic Paste Nitrofurantoin Versus Double Antibiotic Paste

Completed
NCT05254808Phase 3

EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care

Terminated
NCT02789579Early Phase 1

The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy

Unknown
NCT03299387Phase 4

INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI

Withdrawn
NCT02727322Phase 4

Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery

Completed
NCT02911662Not Applicable

Treatment of Asymptomatic Bacteriuria in Pregnancy

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
25